Northwest Biotherapeutics Inc (OTCQB:NWBO)

0.278
Delayed Data
As of 3:51pm ET
 +0.0034 / +1.24%
Today’s Change
0.14
Today|||52-Week Range
0.40
+18.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Operating ActivitiesNet Income / Starting Line-10.3M-23.3M-27.0M-21.5M
 
 
 
 
 
Depreciation44.0K41.0K298.0K365.0K
 
 
 
 
 
Total Other Cash Flow1.1M10.1M16.5M14.2M
 
 
 
 
 
Funds From Operations-9.1M-13.1M-10.2M-7.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-5.4M-7.4M4.6M-2.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-3.7M-5.7M-14.8M-4.8M
 
 
 
 
 
 
InvestingCapital Expenditures-9.0K-5.0K6.0K0.00
 
 
 
 
Fixed Asset Disposal2.0K----0.00
 
 
Other Investing - Sources0.00220.0K0.000.00
 
 
Net Cash Flow Investing-7.0K-5.0K6.0K0.00
 
 
 
 
 
FinancingShort Term Borrowings---699.0K-350.0K4.2M
 
 
 
 
Long Term Borrowings2.5M891.0K4.7M0.00
 
 
 
 
Long Term Debt Reduction-1.5M0.000.00-2.2M
 
 
 
Net Proceeds Stock Sale982.0K7.9M9.9M4.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.00----0.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing3.9M8.1M14.3M6.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-2.4M-1.3M-441.0K-1.9M
 
 
 
 
 
 
Net Change In Cash151.0K2.4M-493.0K2.0M